HomeInsulgen 40iu Injection
Insulgen 40IU Injection

Insulgen 40iu Injection

Last Reviewed: Mar 29, 2026

Insulgen 40 IU Injection – 1 mL Vial

  • Short-acting human insulin 40 IU/mL for controlling post-meal blood sugar.
  • Ideal for adults and children requiring mealtime insulin management.
  • 1 mL multi-dose vial allows precise dosing at home or clinics.

Diabetes Care, Chronic Disease Management, Insulin Therapy, Home Health, Clinic Use Insulgen 40 IU Injection

15,000Tsh/ Unit
1

Product description

Insulgen 40 IU Injection

Insulgen 40 IU Injection is a short-acting human insulin designed to manage postprandial blood glucose in patients with diabetes mellitus. It provides rapid glucose-lowering effects, supporting safe and effective glycemic control in adults and children.

Available Models/Sizes/Variations
  • Vial size: 1 mL containing 40 IU insulin
  • Concentration: 40 IU/mL
Main Intended Uses (with localized benefits)
  • Short-term glycemic control for type 1 diabetes
  • Supplementary insulin for type 2 diabetes
  • Supports safe diabetes management in Tanzanian homes and clinics
Operating Instructions
  1. Inspect vial; solution should be clear and colorless.
  2. Administer subcutaneously using sterile syringe or pen before meals.
  3. Rotate injection sites to prevent lipodystrophy.
  4. Adjust dose according to blood glucose monitoring and medical advice.
  5. Discard vial 4 weeks after first use.
Potential Risks / Adverse Events
  • Hypoglycemia (low blood sugar)
  • Injection site reactions (redness, swelling)
  • Weight gain or rare allergic reactions
Interactions / Compatibility
  • May interact with oral antidiabetic drugs, corticosteroids, beta-blockers, ACE inhibitors, or other medications affecting blood sugar.
Warnings / Precautions (with localized warnings)
  • Store in refrigerator at 2–8°C; do not freeze.
  • Do not mix with other insulins unless prescribed by a doctor.
  • Monitor blood glucose levels regularly.
  • Keep out of reach of children.
Quick Device Facts Table
Item Detail
Device Type Short-acting human insulin
Intended Use Postprandial blood sugar control
Operating Environment Home or clinic; subcutaneous injection
Sterilization Method Single-use syringe or pen required
Potential Risks Hypoglycemia, injection site reactions
Warnings Store 2–8°C; discard after 4 weeks
Mechanism of Operation
Insulgen delivers rapid-acting insulin that lowers post-meal blood glucose by enhancing cellular glucose uptake and suppressing hepatic glucose production.

Welcome Back

Or continue with

Not a member yet? |

Insulgen 40IU Injection | AfyaDepo